Skip Ribbon Commands
Skip to main content

W. Nicholson Price II

W. Nicholson Price II

Professor of Law
Member of University of Michigan Law School Faculty 2016-


Publications

Forthcoming | Books | Book Chapters | Journal Articles | Reviews
Other Publications | Reprints | Works in Progress & Working Papers

Forthcoming


Book Chapters

  • "Biobanks as Innovation Infrastructure for Translational Medicine." In Global Genes, Local Concerns: Legal, Ethical, and Scientific Challenges in International Biobanking, edited by Timo Minssen, Janne R. Herrmann, and Jens Schovsbo, 42-55. Cheltenham, U.K.: Edward Elgar Publishing, 2019.
    MLaw Catalog | U-M Library Search
    Full Text: Elgar Online (UMich users) | Elgar Online
  • "Medical Malpractice and Black-Box Medicine." In Big Data, Health Law, and Bioethics, edited by I. Glenn Cohen et al., 295-306. Cambridge: Cambridge University Press, 2018.
    Full Text: Cambridge Core (UMich users) | Cambridge Core
  • "Innovation Policy Failures in the Manufacturing of Drugs." In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, edited by H. F. Lynch and I. G. Cohen, 343-58. New York: Columbia University Press, 2015. (Work published when author not on Michigan Law faculty.)
    MLaw Catalog

Journal Articles

  • "Shadow Health Records Meet New Data Privacy Laws." Margot E. Kaminski, Timo Minssen, and Kayte Spector-Bagdady, co-authors. Science 363, no. 6426 (2019): 448-50.
    Full Text: WWW
  • "Privacy in the Age of Medical Big Data." I. Glenn Cohen, Nature Medicine 25 (2019): 37-42.
    Full Text: WWW
  • "How Logically Impossible Patents Block Biosimilars." Arti K. Rai, co-author. Nature Biotechnology 37 (2019): 862-3.
    Full Text: WWW
  • "Grants." Berkeley Tech. L.J. 34, no. 1 (2019): 1-65.
    Full Text: MLaw Repository | SSRN | WWW
  • "Drug Approval in a Learning Health System." Minn. L. Rev. 102, no. 6 (2018): 2413-62.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN | WWW
  • "Big Data and Black-Box Medical Algorithms." Science Translational Medicine 10, no. 471 (2018): eaao5333.
    Full Text: WWW
  • "Risk and Resilience in Health Data Infrastructure." Colo. Tech. L.J. 16, no. 1 (2017): 65-85.
    Full Text: SSRN | WWW
  • "Regulating Black-Box Medicine." Mich. L. Rev. 116, no. 3 (2017): 421-74.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN | Lexis | Westlaw
  • "Promoting Healthcare Innovation on the Demand Side." R. S. Eisenberg, co-author. J.L. & Biosciences 4, no. 1 (2017): 3-49.
    Full Text: MLaw Repository | Lexis | Oxford Journals (UMich users) | Oxford Journals | SSRN
  • "Expired Patents, Trade Secrets, and Stymied Competition." Notre Dame L. Rev. 92, no. 4 (2017): 1611-40.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN | Lexis | Westlaw | WWW
  • "Artificial Intelligence in Health Care: Applications and Legal Issues." SciTech Law. 14, no. 1 (2017): 10-3.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN | Westlaw | SSRN
  • "The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases." D. Klonoff, co-author. J. Diabetes Sci. & Tech. 11, no. 2 (2016): 220-3.
    Full Text: WWW
  • "Regulating Secrecy." Wash. L. Rev. 91, no. 4 (2016): 1769-812.
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw
  • "Privacy and Accountability in Black-Box Medicine." R. Ford, co-author. Mich. Telecomm. & Tech. L. Rev. 23, no. 1 (2016): 1-43.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN | Lexis | Westlaw
  • "Manufacturing Barriers to Biologics Competition and Innovation." A. Rai, co-author. Iowa L. Rev. 101, no. 3 (2016): 1023-63.
    Full Text: MLaw Repository | HEIN (UMich users) | HEIN | Lexis | Westlaw | LegalTrac (UMich users) | LegalTrac | SSRN
  • "Codon Influence on Large-Scale Protein Expression Correlates with E. coli mRNA Levels." G. Boel et al., co-authors. Nature 529, no. 7586 (2016): 358-63.
    Full Text: WWW
  • "Big Data, Patents, and the Future of Medicine." Cardozo L. Rev. 37, no. 4 (2016): 1401-53.
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN | WWW
  • "Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?" T. Minssen, co-author. Nature Biotechnology 33, no. 7 (2015): 685-6. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Describing Black-Box Medicine." B.U. J. Sci. & Tech. L. 21, no. 2 (2015): 347-56. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN
  • "Black-Box Medicine." Harv. J.L. & Tech. 28, no. 2 (2015): 419-67. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN
  • "Are Trade Secrets Delaying Biosimilars?" A. Rai, co-author. Science 348, no. 6231 (April 10, 2015): 188-9. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Patent Trolling — Why Bio & Pharmaceuticals Are at Risk." R. Feldman, co-author. Stan. Tech. L. Rev. 17, no. 2 (2014): 773-809. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN
  • "Nudging the FDA." I. G. Cohen, co-author. Am. Int. 10, no. 2 (2014): 35. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Models of Consent to Return of Incidental Findings in Genomic Research." P. S. Appelbaum et al., co-authors. Hastings Ctr. Rep. 44, no. 4 (2014): 22-32. (Work published when author not on Michigan Law faculty.)
    Full Text: Wiley (UMich users) | Wiley
  • "Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing." B.C. L. Rev. 55, no. 2 (2014): 491-562. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN
  • "Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing." IP Theory 4, no. 1 (2014): 1-8. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN
  • "Problems of Innovation-Deficient Pharmaceutical Manufacturing." New Eng. J. Med. (2013): 1-3. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Informed Consent for Return of Incidental Findings in Genomic Research." P. S. Appelbaum et al., co-authors. Genetics in Med. 16, no. 5 (2013): 367-73. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Unblocked Future: Why Gene Patents Won't Hinder Whole-Genome Sequencing and Personalized Medicine." Cardozo L. Rev. 33, no. 4 (2012): 1601-31. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw
  • "Large-Scale Experimental Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. coli." S. K. Handelman et al., co-authors. Microbial Informatics & Experimentation 6, no. 1 (2011): 1-6. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Am I My Son? Human Clones and the Modern Family." Colum. Sci. & Tech. L. Rev. 11 (2010): 119-51. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN
  • "Understanding the Physical Properties that Control Protein Crystallization by Analysis of Large-Sale Experimental Data." Yang Chen et al., co-authors. Nature Biotechnology 27, no. 1 (2009): 51-7. (Work published when author not on Michigan Law faculty.)
    Full Text: WWW
  • "Patenting Race: The Problems of Ethnic Genetic Testing Patents." Colum. Sci. & Tech. L. Rev. 8 (2007): 119-46. (Work published when author not on Michigan Law faculty.)
    Full Text: HEIN (UMich users) | HEIN | Lexis | Westlaw | SSRN
  • "MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity." A. Pacner et al., co-authors. Molecular Diagnosis 7, no. 1 (2003): 17-23. (Work published when author not on Michigan Law faculty.)
    Full Text: Springer (UMich user) | Springer

Other Publications

  • Introduction to "Timing is Everything: Balancing Access and Uncertainty". In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, edited by H. F. Lynch and I. G. Cohen, 247-50. New York: Columbia University Press, 2015. (Work published when author not on Michigan Law faculty.)
    Full Text: DeGruyter (UMich users) | DeGruyter

Forthcoming | Books | Book Chapters | Journal Articles | Reviews
Other Publications | Reprints | Works in Progress & Working Papers

Revised 10/02/2019